Predictors of AAA Expansion and/or Rupture
Stopped We were unable to recruit more subjects who met the inclusion/exclusion criteria and we have closed the study.
Conditions
- Abdominal Aortic Aneurysm (AAA)
Interventions
- DRUG: Assess AAA rupture risk by PET-CTA scans
- DRUG: 18F-fludeoxyglucose (FDG)
- DIAGNOSTIC_TEST: 11C-PBR28
Sponsor
Washington University School of Medicine